Leping Yan

2.0k total citations
40 papers, 1.5k citations indexed

About

Leping Yan is a scholar working on Biomaterials, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Leping Yan has authored 40 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Biomaterials, 14 papers in Molecular Biology and 13 papers in Biomedical Engineering. Recurrent topics in Leping Yan's work include Silk-based biomaterials and applications (13 papers), Bone Tissue Engineering Materials (9 papers) and Electrospun Nanofibers in Biomedical Applications (7 papers). Leping Yan is often cited by papers focused on Silk-based biomaterials and applications (13 papers), Bone Tissue Engineering Materials (9 papers) and Electrospun Nanofibers in Biomedical Applications (7 papers). Leping Yan collaborates with scholars based in China, Portugal and United Kingdom. Leping Yan's co-authors include Rui L. Reis, Joaquím M. Oliveira, Ana L. Oliveira, João F. Mano, Sofia G. Caridade, Rui A. Sousa, Cristina Correia, Gang Wu, Joana Silva‐Correia and Li Ren and has published in prestigious journals such as Scientific Reports, Journal of Controlled Release and Cellular and Molecular Life Sciences.

In The Last Decade

Leping Yan

37 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leping Yan China 18 818 706 271 239 209 40 1.5k
Stephanie Möller Germany 28 511 0.6× 597 0.8× 458 1.7× 289 1.2× 208 1.0× 68 1.9k
Yanbo Zhang China 10 447 0.5× 578 0.8× 378 1.4× 385 1.6× 272 1.3× 11 1.6k
Yuanman Yu China 22 449 0.5× 844 1.2× 251 0.9× 317 1.3× 131 0.6× 39 1.4k
Aileen Crawford United Kingdom 24 843 1.0× 737 1.0× 246 0.9× 493 2.1× 461 2.2× 54 2.0k
Jiabing Fan United States 17 438 0.5× 488 0.7× 272 1.0× 251 1.1× 249 1.2× 20 1.2k
Claudia Loebel United States 21 505 0.6× 921 1.3× 452 1.7× 340 1.4× 163 0.8× 37 2.0k
Christoph Meinert Australia 22 776 0.9× 1.4k 2.0× 257 0.9× 425 1.8× 289 1.4× 52 2.4k
Rogério P. Pirraco Portugal 30 888 1.1× 915 1.3× 431 1.6× 391 1.6× 100 0.5× 71 2.1k
Susanne Bierbaum Germany 24 516 0.6× 1.2k 1.7× 255 0.9× 485 2.0× 218 1.0× 44 2.0k
Elizabeth R. Balmayor Germany 30 674 0.8× 837 1.2× 667 2.5× 690 2.9× 206 1.0× 82 2.4k

Countries citing papers authored by Leping Yan

Since Specialization
Citations

This map shows the geographic impact of Leping Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leping Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leping Yan more than expected).

Fields of papers citing papers by Leping Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leping Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leping Yan. The network helps show where Leping Yan may publish in the future.

Co-authorship network of co-authors of Leping Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Leping Yan. A scholar is included among the top collaborators of Leping Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leping Yan. Leping Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Du, Lihua, Huaping Huang, Wenqing Wang, et al.. (2025). Hyaluronic acid-modified MOF nanoparticles for encapsulating asparaginase in T-cell acute lymphoblastic leukemia treatment. Chinese Chemical Letters. 37(1). 111222–111222. 1 indexed citations
3.
Li, Peishan, et al.. (2025). Involvement of the blaCTX-M-3 gene in emergence of a peculiar resistance phenotype in Klebsiella pneumoniae. Frontiers in Cellular and Infection Microbiology. 15. 1545157–1545157.
4.
Fu, Huafeng, Jie Zhang, Hengxing Chen, et al.. (2025). NPR1 Promotes Lipid Droplet Lipolysis to Enhance Mitochondrial Oxidative Phosphorylation and Fuel Gastric Cancer Metastasis. Advanced Science. 12(37). e03233–e03233. 4 indexed citations
5.
Liu, Yu, et al.. (2024). Enhancing cell pyroptosis with biomimetic nanoparticles for melanoma chemo-immunotherapy. Journal of Controlled Release. 367. 470–485. 22 indexed citations
6.
Liu, Yu, Yunsheng Xu, Xiaobo Wang, et al.. (2023). Elastin-Derived VGVAPG Fragment Decorated Cell-Penetrating Peptide with Improved Gene Delivery Efficacy. Pharmaceutics. 15(2). 670–670. 5 indexed citations
7.
Carvalho, Mariana R., Wei Chen, Leping Yan, et al.. (2023). Microphysiological systems to study colorectal cancer: state-of-the-art. Biofabrication. 15(3). 32001–32001. 14 indexed citations
8.
Li, Huafu, Chunming Wang, Linxiang Lan, et al.. (2022). METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability. Cellular and Molecular Life Sciences. 79(3). 135–135. 89 indexed citations
9.
Liu, Yu, Zhongyuan He, Chongjian Gao, et al.. (2022). In-situ formed elastin-based hydrogels enhance wound healing via promoting innate immune cells recruitment and angiogenesis. Materials Today Bio. 15. 100300–100300. 55 indexed citations
10.
Li, Bo, Mariana R. Carvalho, Huijun Wang, et al.. (2022). Complex in vitro 3D models of digestive system tumors to advance precision medicine and drug testing: Progress, challenges, and trends. Pharmacology & Therapeutics. 239. 108276–108276. 5 indexed citations
11.
Wang, Xiaobo, et al.. (2022). UNC13B Promote Arsenic Trioxide Resistance in Chronic Lymphoid Leukemia Through Mitochondria Quality Control. Frontiers in Oncology. 12. 920999–920999. 3 indexed citations
12.
Li, Huafu, Chunming Wang, Linxiang Lan, et al.. (2021). PARP1 Inhibitor Combined With Oxaliplatin Efficiently Suppresses Oxaliplatin Resistance in Gastric Cancer-Derived Organoids via Homologous Recombination and the Base Excision Repair Pathway. Frontiers in Cell and Developmental Biology. 9. 719192–719192. 11 indexed citations
13.
14.
Yan, Leping, Irene Mencía Castaño, Rukmani Sridharan, et al.. (2020). Collagen/GAG scaffolds activated by RALA-siMMP-9 complexes with potential for improved diabetic foot ulcer healing. Materials Science and Engineering C. 114. 111022–111022. 29 indexed citations
15.
Yan, Leping, Joana Silva‐Correia, Viviana P. Ribeiro, et al.. (2016). Tumor Growth Suppression Induced by Biomimetic Silk Fibroin Hydrogels. Scientific Reports. 6(1). 31037–31037. 73 indexed citations
16.
Yan, Leping, Joana Silva‐Correia, Mariana B. Oliveira, et al.. (2014). Bilayered silk/silk-nanoCaP scaffolds for osteochondral tissue engineering: In vitro and in vivo assessment of biological performance. Acta Biomaterialia. 12. 227–241. 115 indexed citations
17.
Yan, Leping, Joaquím M. Oliveira, Ana L. Oliveira, & Rui L. Reis. (2012). Development of a bilayered scaffold based on silk fibroin and silk fibroin/nano-calcium phosphate for osteochondral regeneration. Journal of Tissue Engineering and Regenerative Medicine. 6. 24–24. 1 indexed citations
18.
Correia, Cristina, Sarindr Bhumiratana, Leping Yan, et al.. (2012). Development of silk-based scaffolds for tissue engineering of bone from human adipose-derived stem cells. Acta Biomaterialia. 8(7). 2483–2492. 192 indexed citations
19.
Yan, Leping, Joaquím M. Oliveira, Ana L. Oliveira, et al.. (2011). Macro/microporous silk fibroin scaffolds with potential for articular cartilage and meniscus tissue engineering applications. Acta Biomaterialia. 8(1). 289–301. 235 indexed citations
20.
Yan, Leping, Yingjun Wang, Li Ren, et al.. (2010). Genipin‐cross‐linked collagen/chitosan biomimetic scaffolds for articular cartilage tissue engineering applications. Journal of Biomedical Materials Research Part A. 95A(2). 465–475. 278 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026